Insights

Growing Market Presence Exelixis operates within the rapidly expanding biotechnology research sector with substantial revenue between one to ten billion dollars, indicating a significant market opportunity for suppliers and partners seeking to engage with a prominent player in cancer treatment development.

Research and Development Focus The company's commitment to innovative drug discovery and development creates potential for collaboration with technology providers, lab equipment suppliers, and contract research organizations aiming to support cutting-edge oncology research efforts.

Strategic Investment Trends Several institutional investors have recently increased their stakes in Exelixis, signaling confidence in its growth prospects and providing openings to financial service firms and investors interested in supporting or offering financial products tailored to biotech growth companies.

Expansion of Staff and Capabilities With a sizable workforce of up to 5000 employees and ongoing commercial efforts, there are opportunities to offer recruitment, HR solutions, and employee engagement platforms to support scalable growth and talent acquisition needs.

Market Ratings and Momentum Exelixis has received a 'Moderate Buy' consensus rating from multiple analysts, highlighting optimism in its market performance and indicating potential for sales of analytical tools, market intelligence services, and strategic consulting to capitalize on its growth trajectory.

Exelixis Tech Stack

Exelixis uses 8 technology products and services including Axway B2Bi, LinkedIn Recruiter, Wdesk, and more. Explore Exelixis's tech stack below.

  • Axway B2Bi
    Api Management
  • LinkedIn Recruiter
    Applicant Tracking Systems
  • Wdesk
    Corporate Performance Management
  • CyberArk
    Identity And Access Management
  • Auth0
    Identity Verification
  • Underscore.js
    Javascript Libraries
  • Microsoft Word
    Office Suites
  • Informatica Master Data Management
    Product Information Management

Media & News

Exelixis's Email Address Formats

Exelixis uses at least 1 format(s):
Exelixis Email FormatsExamplePercentage
FLast@exelixis.comJDoe@exelixis.com
81%
First.Last@exelixis.comJohn.Doe@exelixis.com
11%
FiLast@exelixis.comJoDoe@exelixis.com
5%
FirstLast@exelixis.comJohnDoe@exelixis.com
3%

Frequently Asked Questions

What is Exelixis's phone number?

Minus sign iconPlus sign icon
You can contact Exelixis's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Exelixis's stock symbol?

Minus sign iconPlus sign icon
Exelixis is a publicly traded company; the company's stock symbol is EXEL.

What is Exelixis's official website and social media links?

Minus sign iconPlus sign icon
Exelixis's official website is exelixis.com and has social profiles on LinkedInCrunchbase.

How much revenue does Exelixis generate?

Minus sign iconPlus sign icon
As of December 2025, Exelixis's annual revenue is estimated to be $1.8B.

What is Exelixis's SIC code NAICS code?

Minus sign iconPlus sign icon
Exelixis's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Exelixis have currently?

Minus sign iconPlus sign icon
As of December 2025, Exelixis has approximately 1.5K employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: C. U.Chief Medical Officer And Head Of Clinical Development: C. O.Chief Scientist: J. S. B.. Explore Exelixis's employee directory with LeadIQ.

What industry does Exelixis belong to?

Minus sign iconPlus sign icon
Exelixis operates in the Biotechnology Research industry.

What technology does Exelixis use?

Minus sign iconPlus sign icon
Exelixis's tech stack includes Axway B2BiLinkedIn RecruiterWdeskCyberArkAuth0Underscore.jsMicrosoft WordInformatica Master Data Management.

What is Exelixis's email format?

Minus sign iconPlus sign icon
Exelixis's email format typically follows the pattern of FLast@exelixis.com. Find more Exelixis email formats with LeadIQ.

When was Exelixis founded?

Minus sign iconPlus sign icon
Exelixis was founded in 1994.

Exelixis

Biotechnology ResearchCalifornia, United States1001-5000 Employees

Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat.

After operating in the challenging biotech sector for nearly three decades, we've evolved into a multi-platform cancer company with a proven track record of resiliency in the face of adversity. The success of our flagship commercial product set us up on our journey to discover and develop next-generation cancer treatments, driven by our relentless pursuit of results for the patients we serve. 

Cancer is our cause. Make it yours, too. 

Please see our Community Guidelines: bit.ly/4iBzJU0

For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
EXEL
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1994
Employees
1001-5000

Section iconFunding & Financials

  • $1B$10B

    Exelixis's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1B$10B

    Exelixis's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.